APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Mullerian Hormone (AMH) Test

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-Mullerian Hormone (AMH) Test Industry Growth and Trends Forecast to 2032

4 March 2026113 pages

Choose your research edition.

Industry ResearchAnti-Mullerian Hormone (AMH) Test Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Mullerian Hormone (AMH) Test Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Anti-Mullerian Hormone (AMH) Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Mullerian Hormone (AMH) Test Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Mullerian Hormone (AMH) Test Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

According to APO Research, the global Anti-Mullerian Hormone (AMH) Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-Mullerian Hormone (AMH) Test is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-Mullerian Hormone (AMH) Test is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Mullerian Hormone (AMH) Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Anti-Mullerian Hormone (AMH) Test market include Roche, Beckman Coulter, BioMérieux, Monash IVF, Bumrungrad International Hospital, CTK Biotech, Biotime, Boditech Med and CREATE Fertility, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-Mullerian Hormone (AMH) Test market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-Mullerian Hormone (AMH) Test market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Mullerian Hormone (AMH) Test market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Mullerian Hormone (AMH) Test.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Anti-Mullerian Hormone (AMH) Test market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-Mullerian Hormone (AMH) Test Market by Company

Roche

Beckman Coulter

BioMérieux

Monash IVF

Bumrungrad International Hospital

CTK Biotech

Biotime

Boditech Med

CREATE Fertility

Repromed Fertility Specialists

Quest Health

Clinpath Pathology

Shenzhen YHLO Biotech

Guangzhou Kangrun Biotechnology

Guangzhou Wondfo Biotech

Beijing Savant Biotechnology

Anti-Mullerian Hormone (AMH) Test Segment by Type

Chemiluminescence Immunoassay

ELISA

Magnetic Particle Chemiluminescence

Flow Cytometry Fluorescence Luminescence

Other

Anti-Mullerian Hormone (AMH) Test Segment by Application

Assisted Reproduction

Polycystic Ovary Syndrome

Ovarian Cancer

Other

Anti-Mullerian Hormone (AMH) Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Mullerian Hormone (AMH) Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Mullerian Hormone (AMH) Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Mullerian Hormone (AMH) Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Anti-Mullerian Hormone (AMH) Test companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Anti-Mullerian Hormone (AMH) Test Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Anti-Mullerian Hormone (AMH) Test Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Anti-Mullerian Hormone (AMH) Test Market Share by Region (2021-2026) Table 4. Global Anti-Mullerian Hormone (AMH) Test Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Anti-Mullerian Hormone (AMH) Test Market Share by Region (2027-2032) Table 6. Global Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Anti-Mullerian Hormone (AMH) Test Market Size Share by Type (2021-2026) Table 9. Global Anti-Mullerian Hormone (AMH) Test Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Anti-Mullerian Hormone (AMH) Test Market Size Share Forecasted by Type (2027-2032) Table 11. North America Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Anti-Mullerian Hormone (AMH) Test Market Size Share by Application (2021-2026) Table 24. Global Anti-Mullerian Hormone (AMH) Test Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Anti-Mullerian Hormone (AMH) Test Market Size Share Forecasted by Application (2027-2032) Table 26. North America Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Anti-Mullerian Hormone (AMH) Test Industry Trends Table 37. Anti-Mullerian Hormone (AMH) Test Industry Drivers Table 38. Anti-Mullerian Hormone (AMH) Test Industry Opportunities and Challenges Table 39. Anti-Mullerian Hormone (AMH) Test Industry Restraints Table 40. Global Anti-Mullerian Hormone (AMH) Test Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Company (2021-2026) Table 42. Global Anti-Mullerian Hormone (AMH) Test Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Anti-Mullerian Hormone (AMH) Test Key Company Headquarters & Area Served Table 44. Global Anti-Mullerian Hormone (AMH) Test Company, Product Type & Application Table 45. Global Anti-Mullerian Hormone (AMH) Test Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Anti-Mullerian Hormone (AMH) Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Roche Company Information Table 49. Roche Business Overview Table 50. Roche Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Roche Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 52. Roche Recent Development Table 53. Beckman Coulter Company Information Table 54. Beckman Coulter Business Overview Table 55. Beckman Coulter Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Beckman Coulter Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 57. Beckman Coulter Recent Development Table 58. BioMérieux Company Information Table 59. BioMérieux Business Overview Table 60. BioMérieux Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. BioMérieux Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 62. BioMérieux Recent Development Table 63. Monash IVF Company Information Table 64. Monash IVF Business Overview Table 65. Monash IVF Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Monash IVF Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 67. Monash IVF Recent Development Table 68. Bumrungrad International Hospital Company Information Table 69. Bumrungrad International Hospital Business Overview Table 70. Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 72. Bumrungrad International Hospital Recent Development Table 73. CTK Biotech Company Information Table 74. CTK Biotech Business Overview Table 75. CTK Biotech Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. CTK Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 77. CTK Biotech Recent Development Table 78. Biotime Company Information Table 79. Biotime Business Overview Table 80. Biotime Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Biotime Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 82. Biotime Recent Development Table 83. Boditech Med Company Information Table 84. Boditech Med Business Overview Table 85. Boditech Med Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Boditech Med Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 87. Boditech Med Recent Development Table 88. CREATE Fertility Company Information Table 89. CREATE Fertility Business Overview Table 90. CREATE Fertility Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. CREATE Fertility Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 92. CREATE Fertility Recent Development Table 93. Repromed Fertility Specialists Company Information Table 94. Repromed Fertility Specialists Business Overview Table 95. Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 97. Repromed Fertility Specialists Recent Development Table 98. Quest Health Company Information Table 99. Quest Health Business Overview Table 100. Quest Health Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Quest Health Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 102. Quest Health Recent Development Table 103. Clinpath Pathology Company Information Table 104. Clinpath Pathology Business Overview Table 105. Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 107. Clinpath Pathology Recent Development Table 108. Shenzhen YHLO Biotech Company Information Table 109. Shenzhen YHLO Biotech Business Overview Table 110. Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 112. Shenzhen YHLO Biotech Recent Development Table 113. Guangzhou Kangrun Biotechnology Company Information Table 114. Guangzhou Kangrun Biotechnology Business Overview Table 115. Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 117. Guangzhou Kangrun Biotechnology Recent Development Table 118. Guangzhou Wondfo Biotech Company Information Table 119. Guangzhou Wondfo Biotech Business Overview Table 120. Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 122. Guangzhou Wondfo Biotech Recent Development Table 123. Beijing Savant Biotechnology Company Information Table 124. Beijing Savant Biotechnology Business Overview Table 125. Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 127. Beijing Savant Biotechnology Recent Development Table 128. North America Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2026) Table 131. North America Anti-Mullerian Hormone (AMH) Test Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Anti-Mullerian Hormone (AMH) Test Market Share Forecast by Country (2027-2032) Table 133. Europe Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2026) Table 136. Europe Anti-Mullerian Hormone (AMH) Test Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Anti-Mullerian Hormone (AMH) Test Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2026) Table 141. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Share Forecast by Country (2027-2032) Table 143. Latin America Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2026) Table 146. Latin America Anti-Mullerian Hormone (AMH) Test Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Anti-Mullerian Hormone (AMH) Test Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2026) Table 151. Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Anti-Mullerian Hormone (AMH) Test Product Image Figure 3. Global Anti-Mullerian Hormone (AMH) Test Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 5. Global Anti-Mullerian Hormone (AMH) Test Market Share by Region: 2025 VS 2032 Figure 6. Global Anti-Mullerian Hormone (AMH) Test Market Share by Region (2021-2032) Figure 7. North America Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Chemiluminescence Immunoassay Image Figure 13. Global Chemiluminescence Immunoassay Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. ELISA Image Figure 15. Global ELISA Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Magnetic Particle Chemiluminescence Image Figure 17. Global Magnetic Particle Chemiluminescence Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Flow Cytometry Fluorescence Luminescence Image Figure 19. Global Flow Cytometry Fluorescence Luminescence Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Other Image Figure 21. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Anti-Mullerian Hormone (AMH) Test Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Anti-Mullerian Hormone (AMH) Test Market Share by Type 2025 VS 2032 Figure 24. North America Anti-Mullerian Hormone (AMH) Test Market Size Share by Type (2021-2032) Figure 25. Europe Anti-Mullerian Hormone (AMH) Test Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Share by Type (2021-2032) Figure 27. Latin America Anti-Mullerian Hormone (AMH) Test Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Anti-Mullerian Hormone (AMH) Test Market Size Share by Type (2021-2032) Figure 29. Assisted Reproduction Image Figure 30. Global Assisted Reproduction Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Polycystic Ovary Syndrome Image Figure 32. Global Polycystic Ovary Syndrome Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Ovarian Cancer Image Figure 34. Global Ovarian Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Other Image Figure 36. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Anti-Mullerian Hormone (AMH) Test Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Anti-Mullerian Hormone (AMH) Test Market Share by Application 2025 VS 2032 Figure 39. North America Anti-Mullerian Hormone (AMH) Test Market Size Share by Application (2021-2032) Figure 40. Europe Anti-Mullerian Hormone (AMH) Test Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Share by Application (2021-2032) Figure 42. Latin America Anti-Mullerian Hormone (AMH) Test Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Anti-Mullerian Hormone (AMH) Test Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Anti-Mullerian Hormone (AMH) Test Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Anti-Mullerian Hormone (AMH) Test Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Anti-Mullerian Hormone (AMH) Test Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2032) Figure 49. Europe Anti-Mullerian Hormone (AMH) Test Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Anti-Mullerian Hormone (AMH) Test Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2032) Figure 52. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2032) Figure 55. Latin America Anti-Mullerian Hormone (AMH) Test Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Anti-Mullerian Hormone (AMH) Test Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2032) Figure 58. Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Chemiluminescence Immunoassay
  • ELISA
  • Magnetic Particle Chemiluminescence
  • Flow Cytometry Fluorescence Luminescence
  • Other
Applications
  • Assisted Reproduction
  • Polycystic Ovary Syndrome
  • Ovarian Cancer
  • Other
Companies covered
  • Roche
  • Beckman Coulter
  • BioMérieux
  • Monash IVF
  • Bumrungrad International Hospital
  • CTK Biotech
  • Biotime
  • Boditech Med
  • CREATE Fertility
  • Repromed Fertility Specialists
  • Quest Health
  • Clinpath Pathology
  • Shenzhen YHLO Biotech
  • Guangzhou Kangrun Biotechnology
  • Guangzhou Wondfo Biotech
  • Beijing Savant Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Anti-Mullerian Hormone (AMH) Test Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Anti-Mullerian Hormone (AMH) Test Market Size by Region (2021-2032)
  5. 1.4.1 Global Anti-Mullerian Hormone (AMH) Test Market Size by Region (2021-2026)
  6. 1.4.2 Global Anti-Mullerian Hormone (AMH) Test Market Size by Region (2027-2032)
  7. 1.5 Key Regions Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032)
  8. 1.5.1 North America Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (2021-2032)
2 Anti-Mullerian Hormone (AMH) Test Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Chemiluminescence Immunoassay
  3. 2.1.2 ELISA
  4. 2.1.3 Magnetic Particle Chemiluminescence
  5. 2.1.4 Flow Cytometry Fluorescence Luminescence
  6. 2.1.5 Other
  7. 2.2 Global Anti-Mullerian Hormone (AMH) Test Market Size by Type
  8. 2.2.1 Global Anti-Mullerian Hormone (AMH) Test Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Anti-Mullerian Hormone (AMH) Test Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Anti-Mullerian Hormone (AMH) Test Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Anti-Mullerian Hormone (AMH) Test Market Size by Regions
  12. 2.3.1 North America Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Type (2021-2026)
3 Anti-Mullerian Hormone (AMH) Test Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Assisted Reproduction
  3. 3.1.2 Polycystic Ovary Syndrome
  4. 3.1.3 Ovarian Cancer
  5. 3.1.4 Other
  6. 3.2 Global Anti-Mullerian Hormone (AMH) Test Market Size by Application
  7. 3.2.1 Global Anti-Mullerian Hormone (AMH) Test Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Anti-Mullerian Hormone (AMH) Test Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Anti-Mullerian Hormone (AMH) Test Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Anti-Mullerian Hormone (AMH) Test Market Size by Regions
  11. 3.3.1 North America Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Anti-Mullerian Hormone (AMH) Test Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Anti-Mullerian Hormone (AMH) Test Industry Trends
  2. 4.2 Anti-Mullerian Hormone (AMH) Test Industry Drivers
  3. 4.3 Anti-Mullerian Hormone (AMH) Test Industry Opportunities and Challenges
  4. 4.4 Anti-Mullerian Hormone (AMH) Test Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Anti-Mullerian Hormone (AMH) Test Revenue (2021-2026)
  2. 5.2 Global Anti-Mullerian Hormone (AMH) Test Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Anti-Mullerian Hormone (AMH) Test Key Company Headquarters & Area Served
  4. 5.4 Global Anti-Mullerian Hormone (AMH) Test Company, Product Type & Application
  5. 5.5 Global Anti-Mullerian Hormone (AMH) Test Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Anti-Mullerian Hormone (AMH) Test Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Anti-Mullerian Hormone (AMH) Test Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Anti-Mullerian Hormone (AMH) Test Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Roche Anti-Mullerian Hormone (AMH) Test Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Beckman Coulter
  8. 6.2.1 Beckman Coulter Company Information
  9. 6.2.2 Beckman Coulter Business Overview
  10. 6.2.3 Beckman Coulter Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Beckman Coulter Anti-Mullerian Hormone (AMH) Test Product Portfolio
  12. 6.2.5 Beckman Coulter Recent Developments
  13. 6.3 BioMérieux
  14. 6.3.1 BioMérieux Company Information
  15. 6.3.2 BioMérieux Business Overview
  16. 6.3.3 BioMérieux Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 BioMérieux Anti-Mullerian Hormone (AMH) Test Product Portfolio
  18. 6.3.5 BioMérieux Recent Developments
  19. 6.4 Monash IVF
  20. 6.4.1 Monash IVF Company Information
  21. 6.4.2 Monash IVF Business Overview
  22. 6.4.3 Monash IVF Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Monash IVF Anti-Mullerian Hormone (AMH) Test Product Portfolio
  24. 6.4.5 Monash IVF Recent Developments
  25. 6.5 Bumrungrad International Hospital
  26. 6.5.1 Bumrungrad International Hospital Company Information
  27. 6.5.2 Bumrungrad International Hospital Business Overview
  28. 6.5.3 Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Product Portfolio
  30. 6.5.5 Bumrungrad International Hospital Recent Developments
  31. 6.6 CTK Biotech
  32. 6.6.1 CTK Biotech Company Information
  33. 6.6.2 CTK Biotech Business Overview
  34. 6.6.3 CTK Biotech Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 CTK Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
  36. 6.6.5 CTK Biotech Recent Developments
  37. 6.7 Biotime
  38. 6.7.1 Biotime Company Information
  39. 6.7.2 Biotime Business Overview
  40. 6.7.3 Biotime Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Biotime Anti-Mullerian Hormone (AMH) Test Product Portfolio
  42. 6.7.5 Biotime Recent Developments
  43. 6.8 Boditech Med
  44. 6.8.1 Boditech Med Company Information
  45. 6.8.2 Boditech Med Business Overview
  46. 6.8.3 Boditech Med Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Boditech Med Anti-Mullerian Hormone (AMH) Test Product Portfolio
  48. 6.8.5 Boditech Med Recent Developments
  49. 6.9 CREATE Fertility
  50. 6.9.1 CREATE Fertility Company Information
  51. 6.9.2 CREATE Fertility Business Overview
  52. 6.9.3 CREATE Fertility Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 CREATE Fertility Anti-Mullerian Hormone (AMH) Test Product Portfolio
  54. 6.9.5 CREATE Fertility Recent Developments
  55. 6.10 Repromed Fertility Specialists
  56. 6.10.1 Repromed Fertility Specialists Company Information
  57. 6.10.2 Repromed Fertility Specialists Business Overview
  58. 6.10.3 Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Product Portfolio
  60. 6.10.5 Repromed Fertility Specialists Recent Developments
  61. 6.11 Quest Health
  62. 6.11.1 Quest Health Company Information
  63. 6.11.2 Quest Health Business Overview
  64. 6.11.3 Quest Health Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Quest Health Anti-Mullerian Hormone (AMH) Test Product Portfolio
  66. 6.11.5 Quest Health Recent Developments
  67. 6.12 Clinpath Pathology
  68. 6.12.1 Clinpath Pathology Company Information
  69. 6.12.2 Clinpath Pathology Business Overview
  70. 6.12.3 Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Product Portfolio
  72. 6.12.5 Clinpath Pathology Recent Developments
  73. 6.13 Shenzhen YHLO Biotech
  74. 6.13.1 Shenzhen YHLO Biotech Company Information
  75. 6.13.2 Shenzhen YHLO Biotech Business Overview
  76. 6.13.3 Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
  78. 6.13.5 Shenzhen YHLO Biotech Recent Developments
  79. 6.14 Guangzhou Kangrun Biotechnology
  80. 6.14.1 Guangzhou Kangrun Biotechnology Company Information
  81. 6.14.2 Guangzhou Kangrun Biotechnology Business Overview
  82. 6.14.3 Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio
  84. 6.14.5 Guangzhou Kangrun Biotechnology Recent Developments
  85. 6.15 Guangzhou Wondfo Biotech
  86. 6.15.1 Guangzhou Wondfo Biotech Company Information
  87. 6.15.2 Guangzhou Wondfo Biotech Business Overview
  88. 6.15.3 Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
  90. 6.15.5 Guangzhou Wondfo Biotech Recent Developments
  91. 6.16 Beijing Savant Biotechnology
  92. 6.16.1 Beijing Savant Biotechnology Company Information
  93. 6.16.2 Beijing Savant Biotechnology Business Overview
  94. 6.16.3 Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio
  96. 6.16.5 Beijing Savant Biotechnology Recent Developments
7 North America
  1. 7.1 North America Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
  3. 7.3 North America Anti-Mullerian Hormone (AMH) Test Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
  3. 8.3 Europe Anti-Mullerian Hormone (AMH) Test Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
  3. 10.3 South America Anti-Mullerian Hormone (AMH) Test Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst